Jadran - Galenski Laboratorij d.d. Sustainability Profile
Jadran - Galenski Laboratorij d.d., commonly known as JGL, is a prominent pharmaceutical company headquartered in Croatia (HR). Established in 1991, JGL has made significant strides in the healthcare sector, focusing on the development, production, and distribution of innovative pharmaceutical products. The company operates primarily in the European market, with a strong presence in various regions. JGL is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and medical devices, particularly in the fields of otorhinolaryngology and dermatology. What sets JGL apart is its commitment to research and development, ensuring high-quality standards and unique formulations that cater to specific health needs. With a solid market position and numerous accolades, JGL continues to be a key player in the pharmaceutical industry, dedicated to improving patient outcomes and advancing healthcare solutions.
DitchCarbon Score
How does Jadran - Galenski Laboratorij d.d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jadran - Galenski Laboratorij d.d.'s score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jadran - Galenski Laboratorij d.d.'s reported carbon emissions
In 2023, Jadran - Galenski Laboratorij d.d. reported total carbon emissions of approximately 4,202,000 kg CO2e, encompassing both Scope 1 and Scope 2 emissions. This marks an increase from 2022, when emissions were about 3,445,000 kg CO2e, and a significant rise from 2021's total of approximately 2,436,000 kg CO2e. The company's emissions intensity for 2023 was calculated at about 0.0181 kg CO2e per unit of revenue. Despite the increase in emissions, Jadran - Galenski Laboratorij d.d. has not disclosed any specific reduction targets or initiatives as part of their climate commitments. There are no reported commitments to frameworks such as the Science Based Targets initiative (SBTi) or other climate pledges. The absence of reduction targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, while Jadran - Galenski Laboratorij d.d. has made strides in tracking its emissions, the lack of reduction initiatives indicates a need for further action to align with industry standards for climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
How Carbon Intensive is Jadran - Galenski Laboratorij d.d.'s Industry?
How Carbon Intensive is Jadran - Galenski Laboratorij d.d.'s Location?
Jadran - Galenski Laboratorij d.d.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jadran - Galenski Laboratorij d.d. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
